Development Milestone for Adnavance's MRSA Dx Triggers $1.8M in Financing | GenomeWeb
NEW YORK (GenomeWeb News) - Adnavance Technologies said this week that it has met a milestone in the development of its diagnostic test for methicillin-resistant Staphylococcus aureus that has enabled the second tranche of a previously disclosed series B financing round.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.